Market Trends of Global Brucellosis Vaccines Industry
This section covers the major market trends shaping the Brucellosis Vaccines Market according to our research experts:
Cattles Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Increasing cattle population and key developments like acquisitions by market players are expected to increase segmental growth. For instance, according to the January 2022 report of the United States Department of Agriculture (USDA), there were about 91.9 million cattle and calves in the United States. Similarly, according to the September 2021 report of the USDA, the population of cattle in India is expected to increase and reach 306.7 million in 2022. Hence, the increasing population of cattle is expected to drive demand for more brucellosis vaccines which is anticipated to boost the segment's growth.
Furthermore, many governments across the world are launching a brucellosis vaccination program for cattle and other animals to eradicate brucellosis which is further expected to have a significant positive impact on the studied market. For example, the Government of India is running a flagship scheme called the National Animal Disease Control Program (NADCP) to control foot and mouth disease (FMD) and Brucellosis by vaccinating 100% cattle, buffalo, sheep, goat, and pig population for FMD and 100% bovine female calves of 4-8 months of age for brucellosis over five years period of 2019-2024 with a budget of INR 13,343 crore. Therefore, owing to the above-mentioned factors, the cattle segment is expected to have a significant share in the brucellosis vaccines market over the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
The North American region is expected to have a significant share in the brucellosis vaccines market owing to the factors such as the presence of a large animal population, high burden of brucellosis and increasing awareness about animal health, and the presence of key market players in the region, along with other factors. For instance, as per the January 2022 estimates by Statistics Canada, cattle, and calf slaughter for the period from July to December 2021 was up 0.7% from the same period in 2020 and reached the highest level seen since the second half of 2009 and as of January 1, 2022, Canadian farmers had 11.1 million cattle and calves on their farm.
Further, as per the 2022 update of the United States Department of Agriculture, commercial beef production in the United States is increased over the years totaling 27.6 billion pounds in 2020, with a total value of USD 6.8 billion and this data shows high production and increasing demand for meat products which is expected to have a significant impact on the studied market in the region. Further, the ongoing research and development activities along with new developments from the key market players in the region are expected to boost the market growth. For instance, according to a research study published in July 2021, titled 'Immune Responses and Efficacy of Brucella Abortus Strain RB51 in Bison After Delivery in a Dry Dart Formulation or by Parenteral Inoculation', while statistically stronger than in control animals, the humoral responses against RB51 induced by the dry dart formulation appear to be less pronounced on the ELISA than those induced by parenteral vaccination of bison and these reactions are also transient because they are only seen 4 and 8 weeks after the initial vaccination, and thus, positive results from studies like these are further expected to impact the market's growth. Therefore, owing to the above-mentioned factors, the brucellosis vaccine market is expected to grow over the forecast period of the study in the North American region.
